Stock Events

Bio-Rad Laboratories 

€256
90
+€0+0% Friday 13:29

Statistics

Day High
256
Day Low
256
52W High
-
52W Low
-
Volume
0
Avg. Volume
-
Mkt Cap
7.34B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

7MayConfirmed
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
2.15
2.63
3.11
3.59
Expected EPS
2.15
Actual EPS
2.29

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BUW.F. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Thermo Fisher Scientific
TMO
Mkt Cap209.21B
Thermo Fisher Scientific offers a broad range of products and services in the life sciences sector, directly competing with Bio-Rad's offerings in laboratory equipment and consumables.
Danaher
DHR
Mkt Cap177.21B
Danaher Corporation operates in similar segments as Bio-Rad, including life sciences and diagnostics, making them direct competitors in multiple product lines.
Illumina
ILMN
Mkt Cap17.29B
Illumina specializes in genomics and DNA sequencing technologies, competing with Bio-Rad's products in the genomics field.
Agilent Technologies
A
Mkt Cap36.87B
Agilent Technologies competes with Bio-Rad in the life sciences and diagnostics sectors, particularly in laboratory instruments and supplies.
Bio-Rad Laboratories - Ordinary Shares
BIO.B
Mkt Cap7.93B
Bio-Rad Laboratories Class B shares represent a different class of stock of the same company but are listed separately, directly tied to the company's performance.
Waters
WAT
Mkt Cap16.98B
Waters Corporation provides analytical instruments for the life sciences sector, competing with Bio-Rad's chromatography and mass spectrometry products.
Bruker
BRKR
Mkt Cap8.96B
Bruker Corporation is a competitor in the life science analytical and diagnostic instruments sector, directly competing with several of Bio-Rad's product lines.
Qiagen NV
QGEN
Mkt Cap9.38B
QIAGEN is a provider of sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research, competing with Bio-Rad in the diagnostics and research sectors.
Baxter International
BAX
Mkt Cap17.79B
Baxter International operates in the medical devices and life sciences fields, competing with Bio-Rad in the broader healthcare and scientific research sectors.

About

Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Show more...
CEO
Mr. Norman D. Schwartz
Employees
8000
Country
US
ISIN
US0905721082
WKN
000862449

Listings